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Lipolysis is deﬁned as the catabolism of triacylglycerols (TGs) stored in cellular lipid droplets. Recent
discoveries of essential lipolytic enzymes and characterization of numerous regulatory proteins and
mechanisms have fundamentally changed our perception of lipolysis and its impact on cellular meta-
bolism. Adipose triglyceride lipase (ATGL) is the rate-limiting enzyme for TG catabolism in most cells and
tissues. This review focuses on recent advances in understanding the (patho)physiological impact due to
defective lipolysis by ATGL deﬁciency on mitochondrial (dys)function. Depending on the type of cells and
tissues investigated, absence of ATGL has pleiotropic roles in mitochondrial function.
 2013 The Authors. Published by Elsevier Masson SAS. Open access under CC BY-NC-ND license.1. Introduction
Lipolysis provides free fatty acids (FFAs) depending on meta-
bolic need (e.g. during fasting). FAs are essential substrates for
energy production and lipid synthesis, including membrane lipids
and lipid intermediates involved in cellular signaling. Despite
their fundamental physiological importance, an excess of FFAs
results in lipotoxicity. Lipotoxic effects impair membrane function
and induce endoplasmic reticulum (ER) stress, mitochondrial
dysfunction, inﬂammation, and cell death. Essentially all cells are
able to detoxify FFAs by esteriﬁcation within triacylglycerols
(TGs). Since most cells have a limited capacity to accumulate
excess fat, adipose tissue stores TGs during feeding and supplies
FAs to other tissues during calorie restriction [1]. When the limit
of adipose tissue expansion to store excess nutrients has been
reached lipids accumulate in other tissues [2]. Thereby adipose
tissue protects non-adipose tissues from ectopic lipid spillover,T, brown adipose tissue; DG,
tty acids; PGC-1, peroxisome
tor-1; PPAR, peroxisome
AT, white adipose tissue; Wt,
x: þ43 316 380 9615.
Kratky).
r Masson SAS. Open access under CC BY-which otherwise would result in cell death and impaired organ
function.2. Role of ATGL in neutral lipolysis
Intracellular lipid catabolizing enzymes degrade neutral lipids
such as TGs and cholesteryl esters and theirmetabolic intermediates,
which are stored in cytosolic lipid droplets. Lipid droplet-associated
cholesteryl esters are hydrolyzed by neutral cholesteryl ester hy-
drolase(s) including hormone-sensitive lipase [3]. In 2004, three
groups independently published the discovery of an enzyme able to
hydrolyze TGs and named it adipose triglyceride lipase (ATGL) [4],
desnutrin [5], or calcium-independent phospholipase A2 (iPLA2) [6].
ATGL selectively performs the ﬁrst step in TG hydrolysis, resulting in
the formation of diacylglycerol (DG) and FFA. For maximal lipolytic
activity ATGL requires CGI-58 as a co-activator [7]. G0S2 (predomi-
nantly expressed in adipose tissue and liver) has been identiﬁed as a
selective inhibitor of ATGL [8]. It has been proposed recently that
CGI-58 and G0S2 regulate ATGL via non-competingmechanisms [9].
ATGL is so far the only known lipase that hydrolyzes TGs
selectively at the sn-2 position of the glycerol backbone [10]. Upon
stimulation of the enzyme by its co-activator CGI-58, the stereo/
regioselectivity of ATGL broadens to the sn-1 position, leading to
increased FA release. sn-1,3 DG is the preferred substrate for the
consecutive hydrolysis by hormone-sensitive lipase. ATGL exhibits
10-fold higher substrate speciﬁcity for TGs than for DGs [4] and
shows low transacylase and phospholipase activity [6]. In contrastNC-ND license.
Table 1
Brief summary of major ATGL-related ﬁndings in various tissues and cells.
Tissue Mitochondrial
dysfunction
Major
ﬁndings
Cardiac muscle Yes Severe impairment of cardiac mitochondrial function in Atgl/ hearts due to
lack of FA as ligands for the PPARaePGC-1 complex
Skeletal muscle No Unchanged energy status and mitochondrial oxidative capacity in Atgl/ skeletal muscles
Liver No Upregulation of PGC-1a and b in Atgl/ liver indicate unchanged or increased hepatic mitochondrial activity
White adipose
tissue
? Reduced mitochondrial function and increased ER stress in Atgl/ white adipose tissue; no signiﬁcant
changes in mRNA expression and biological processes
Brown adipose
tissue
Yes Defective PPARa and g ligand production in Atgl/ brown adipocytes results in reduced mitochondrial
FA oxidation and oxidative phosphorylation
Brain No Sparse FA b-oxidation in the brain argues against an important role of ATGL in this
process in the brain; no neurodegeneration in Atgl/ mice
Small intestine No Reduced mRNA expression of genes involved in FA b-oxidation but unchanged PGC-1a mRNA
and intact mitochondria in Atgl/ small intestine
Macrophages Yes Induction of the mitochondrial apoptosis pathway, ER stress, and fragmented mitochondria in Atgl/ macrophages
INS832/13 cells No Unchanged mitochondrial membrane potential, glucose and FA oxidation indicate intact
mitochondrial function in shAtgl pancreatic cells
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DGs, monoacylglycerols, cholesteryl esters, or retinyl esters [4].
ATGL is expressed in most tissues of the body with highest
mRNA levels and enzyme activity found in white (WAT) and brown
adipose tissue (BAT) (reviewed in Ref. [11]). The important role of
ATGL in lipolysis became evident from observations in Atgl-
deﬁcient (/) mice, which accumulate TGs in essentially all or-
gans [12]. Massive TG accumulation caused by impaired TG mobi-
lization in cardiac myocytes results in cardiac failure and premature
death of Atgl/ mice, starting at the age of 12 weeks. Due to the
reduced availability of FFAs as energy substrate, Atgl/mice show
an increased utilization of carbohydrates as energy source, leading
to improved glucose tolerance and insulin sensitivity. Atgl/male
mice are fertile, whereas females lack the ability to suckle their
offspring due to impaired milk production. Plasma FA, TG, total
cholesterol, HDL-cholesterol and ketone body concentrations are
decreased in both fed and fasted Atgl/mice [12]. Major ﬁndings
in various Atgle/e tissues and cells are summarized in Table 1.
3. ATGL deﬁciency and mitochondrial dysfunction
3.1. Cardiac muscle
Although TG accumulation occurs in essentially all organs, none
of them is as much affected as the heart (Fig. 1). Although the
overall morphology of mitochondria and the structure of mito-
chondrial cristae appear intact in electron micrographs (Fig. 1),
mitochondrial size compared to that of wild-type (Wt) mice is
increased [14]. The drastic cardiac phenotype with massive lipid
accumulation and cardiomyopathy was initially thought to result in
the premature death of Atgl/mice [12]. Mice lacking ATGL in all
tissues except cardiac muscle (Atgl-ko/CM) have normal life ex-
pectancy and no physiological difﬁculties [13]. Haemmerle et al.
have very recently shown that heart failure in Atgl/ mice is not
caused by lipid accumulation per se but is a net result of a severe
impairment of cardiac mitochondrial function [14]. ATGL-mediated
lipolysis of cellular TG depots, thereby delivering ligands for the
PPARaePGC-1 complex, is crucial for normal cardiac functioning.
Severely reduced oxygen consumption under both basal and
succinate-stimulated conditions in heart homogenates of Atgl/
mice indicate mitochondrial defect regardless of the presence of
glucose or palmitate, suggesting that the substrate energy source
does not rescue themitochondrial defect. The authors proposed the
following mechanism: after entering the cell, exogenous FAs are
activated and either enter mitochondria for oxidation or are re-
esteriﬁed and stored within lipid droplets. ATGL-mediatedhydrolysis of TG stores is critical to provide ligands for functional
signaling by the PPARaePGC-1 complex, which activates mito-
chondrial biogenesis and oxidative phosphorylation. Importantly,
the lipolytic defect in the heart of Atgl/ mice is able to be
bypassed by PPARa agonist treatment. Fenoﬁbrate and/orWy16453
restores the cardiac expression of PGC-1a and PGC-1b, reverses
systemic lipid accumulation, normalizes oxidative function in
mitochondria, improves cardiac performance, and prevents lethal
cardiomyopathy [14]. These data open the possibility of clinical
application of PPARa or non-selective PPAR agonists for the treat-
ment of patients with neutral lipid storage disease with myopathy.
3.2. Skeletal muscle
Compared with other non-adipose tissues, ATGL mRNA expres-
sion in murine skeletal muscle is quite high [4], suggesting an
important role for ATGL in this metabolically active tissue. Intra-
myocellular TGs localizedwithin cytoplasmic lipid droplets serve as
a reservoir for lipoprotein-derived FAs [15], which are esteriﬁed into
TGs [16,17] prior to mobilization by ATGL. Whole body ATGL deﬁ-
ciency in mice leads to 44% decrease in TG hydrolase activity and
concomitant signiﬁcant TG accumulation in myocytes, predomi-
nantly in oxidative ﬁbres [12]. In linewith these data, ATGL siRNA in
myotubes reduces TG hydrolase activity and increases TG content,
whereas retroviral-mediated ATGL overexpression induces the
reciprocal response and increases theoxidationof FAs liberated from
TGs and DGs [18]. Endurance exercise training increases skeletal
muscle ATGL protein by 2-fold and reduces intramyocellular TG
content in healthy young men [19]. These data conﬁrm the impor-
tance of ATGL for lipid and energy metabolism in skeletal muscle.
The localization of lipid droplets in close proximity to the ER and
mitochondrial network [20] might be crucial for the cellular
economy of myocytes. Skeletal muscle is quantitatively the most
prominent site for FA uptake [18]. Of particular importance is the
activity of skeletal muscle during exercise, which increases the
mitochondrial volume up to 50% after only fewweeks in previously
untrained subjects [21]. Similar data showing stimulating effect of
exercise on mitochondrial biogenesis are observed in rats [22] and
mice [23]. ATGL is essential for efﬁcient lipolysis of intramyocellular
TGs and supply of FAs for mitochondrial b-oxidation [13,24,25]. An
impaired capacity for exercise-induced lipolysis despite even
increased oxidative capacity is observed in skeletal muscles of
Atgl/mice [24]. Being unable to efﬁciently hydrolyze TGs in the
absence of ATGL carbohydrate metabolism is induced, resulting in
elevated muscle and liver glycogen depletion. Reduced maximal
running velocity and endurance capacity in Atgl/mice is not due
Fig. 1. Transmission electron micrographs of heart sections from Wt and Atgl/ mice. Heart tissue was dissected using a Zeiss OPI1 surgical microscope (Carl Zeiss, Oberkochen,
Germany). Small tissue fragments were ﬁxed in 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 2 h, postﬁxed in 2% osmium tetroxide for 2 h at
room temperature, dehydrated in graded series of ethanol, and embedded in a TAAB epoxy resin. Sections (70 nm thick) were contrasted with uranyl acetate and lead citrate. Images
were taken using an FEI Tecnai G2 20 transmission electron microscope (FEI Eindhoven, Eindhoven, Netherlands) with a Gatan ultrascan 1000 CCD camera. Acceleration voltage used
was 120 kV. Wt cardiac muscle sections (upper panels) show a intermyoﬁbrillar network containing mitochondria (M). Atgl/ cardiac muscle (lower panels) show a massive lipid
droplet (LD) accumulation within the intermyoﬁbrillar network. Overall morphology of mitochondria and the structure of mitochondrial cristae appeared normal. Mitochondrial
size compared to that of Wt mice is increased [14]. Left panels: scale bars 1 mm; right panels: scale bars 0.5 mm.
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essential for maintaining normal physiology, especially during ex-
ercise training. To exclude cardiac malfunction, themost prominent
phenotype of Atgl/ mice [12], Schoiswohl et al. have generated
Atgl/ mice that express ATGL only in cardiac muscle (Atgl-ko/
CM) [13]. In contrast to whole body Atgl/mice, Atgl-ko/CMmice
do not accumulate TGs in the heart and have a normal life expec-
tancy. However, both mouse lines are unable to increase circulating
FA levels during exercise. The reduced availability of FAs is
compensated by an increased use of carbohydrates for energy
conversion, leading to rapid depletion of liver glycogen stores
during exercise [13]. To explain decreased force production and
higher muscle relaxation times of Atgl/ mice Nunes et al.
measured mitochondrial oxidative phosphorylation [25]. Despite a
highly increased intramyocellular lipid pool skeletal muscles from
Atgl/ show a comparable energy status and overall muscular
in vivo mitochondrial oxidative capacity as Wt mice. According to
these data mitochondrial dysfunction is likely not responsible for
poor Atgl/ muscle performance.
3.3. Liver
Inconsistent results are published on TG accumulation in livers
of Atgl/mice with almost identical [26], 2.3-fold [12] or at least
3-fold increased hepatic TG concentrations [27] compared with Wt
livers. Electron microscopy reveals lipid droplet accumulation in
Atgl/ livers with morphologically intact mitochondriasurrounded by rough ER (Fig. 2). Using an adenovirus-mediated
approach, Watt et al. [28] have very recently demonstrated that
hepatic ATGL deﬁciency leads to hepatic steatosis without impair-
ing hepatic insulin sensitivity. Intraperitoneal injections of tunica-
mycin induce hepatic steatosis in Atgl/ but not in Wt mice [26].
Thus deﬁciency of liver ATGL causes progressive hepatic steatosis
but inﬂammatory and ﬁbrotic responses are reduced compared
with those reported in other obesity models with similar degrees of
steatosis [27]. Livers from Atgl/ mice might be protected from
hepatic ER stress and inﬂammation through alterations in FA
composition. The authors conclude that ATGL-mediated TG hy-
drolysis might be a novel target in the treatment of hepatic ER
stress [26], which is typically present in patients suffering from
non-alcoholic fatty liver disease and steatohepatitis. Hepatic ATGL
deﬁciency leads to lowering of mitochondrial b-oxidation without
affecting very low-density lipoprotein secretion [29]. Mice deﬁcient
in liver ATGL exhibit 40e70% reduced mRNA expression of hepatic
PPARa and its target genes involved in FA utilization and glucose
production [29]. Consistent with these data, hepatic mitochondrial
oxidation is down-regulated in high fat diet-fed mice administered
Atgl shRNA adenovirus in comparison with controls [28]. Treat-
ment with the PPARa agonist fenoﬁbrate, however, cannot over-
come the decreased expression of PPARa target genes in mice
transduced with Atgl shRNA, suggesting that in the liver ATGL
regulates PPARa through a ligand-independent mechanism.
Knockdown of hepatic ATGL by adenoviral infection results in a
higher respiratory quotient during food withdrawal, indicating that
Fig. 2. Transmission electron micrographs of liver sections fromWt and Atgl/mice. Wt liver cells (upper panels) showmitochondria (M) homogenous in appearance surrounded
by rough endoplasmic reticulum (ER). Atgl/ liver cells (lower panels) show a massive lipid droplet (LD) accumulation with morphologically intact mitochondria within the liver
cells. Left panels: scale bars 1 mm; right panels: scale bars 0.5 mm.
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improved glucose tolerance [28]. In contrast to cardiac ATGL deﬁ-
ciency, hepatic ATGL deﬁciency leads to an upregulation of PGC-1a
and PGC-1b, indicating unchanged or even increased hepatic
mitochondrial biosynthesis [14]. Liver-speciﬁc Atgl/ mice have
an increased number of lipolysosomes, suggesting that lysosomal
TG degradation might reduce hepatic steatosis under conditions of
ATGL deﬁciency [27].
In summary, absence of hepatic ATGL results in steatosis
without inﬂammation [27], downregulation of PPARa target genes
and consequently reduced b-oxidation [29]. Improved hepatic
glucose tolerance but normal hepatic insulin signaling [28] and
protection from tunicamycin-induced ER stress [26] argue for
beneﬁcial effects of ATGL deﬁciency on the liver.
3.4. Adipose tissues
Atgl/ mice have enlarged fat depots, which is mostly pro-
nounced in BAT [12]. In WAT, hormone-stimulated lipolysis is
drastically reduced, indicating that ATGL is hormone-regulated via
direct or indirect mechanisms. The transcriptional response to
products of lipolysis in WAT and BAT reﬂects the functional differ-
ences of lipolysis in these tissues. In WAT mobilized FAs are
released, whereas in BAT FAs activate uncoupling protein 1 and
provide fuel for thermogenesis [30]. Thus Atgl/ mice exhibit
defective thermogenesis. ATGL may also affect PPARg function
since rosiglitazone-mediated PPARg activation and lipid accumu-
lation are associated with increased lipolysis and ATGL expression
in rat adipose tissue [31]. Although increases in WAT mass andadipocyte volume have broad metabolic consequences including
reduced mitochondrial function and increased ER stress [32,33],
microarray studies inWAT of Atgl/mice revealed only moderate
changes in the levels of transcripts associated with identiﬁable
biological processes [34]. To our knowledge, no studies investi-
gating mitochondrial function in Atgl/ white adipocytes have
been published so far. In contrast, microarray results from BAT
indicate that ATGL deﬁciency results in decreased mRNA expres-
sion of genes involved in FA b-oxidation [34] and leads to down-
regulation of PPARa target genes in BAT [35]. Another study
conﬁrms that knockdown of ATGL signiﬁcantly reduces the in-
duction of the rate-limiting enzymes for mitochondrial FA b-
oxidation [36]. Lipolysis is required for maximal induction of
thermogenic genes by b-adrenergic receptor activation in BAT.
Brown adipocytes lacking ATGL are fully responsive to exogenous
PPARa and PPARd ligands for increasing the expression of genes
involved in FA oxidation and oxidative phosphorylation, indicating
that the defect in gene regulation involves ATGL-dependent pro-
duction of PPAR ligands. The authors conclude that in BAT ATGL is
required for the maximal induction of genes involved in FA oxida-
tion and mitochondrial electron transport [36].
3.5. Macrophages
Efﬁcient FA oxidation and ATP synthesis depend on substrate
availability, effective FA transport into themitochondria, and efﬁcient
mitochondrial function. The marked downregulation of the PPAR
target genes carnitine palmitoyltransferase 1a and long chain acyl-
CoA dehydrogenase, the decrease of total acyl-CoA concentrations,
Fig. 3. Transmission electron micrographs of macrophages from Wt and Atgl/ mice. Wt macrophages show mitochondria (M) with intact cristae. Atgl/ macrophages, which
accumulate lipid droplets (LD), exhibit smaller, electron-light mitochondria with aberrant cristae. Treatment of Atgl/ macrophages with the ceramide synthase inhibitor
fumonisin B1 (FB1) normalizes mitochondria size and morphology [40]. Scale bars: 0.2 mm.
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esters [37] are indicators of mitochondrial dysfunction in Atgl/
macrophages. Decreased concentrations of acetyl-CoA suggest
defective mitochondrial b-oxidation, implicating that less NADH and
FADH2 are available for oxidative phosphorylation to drive ATP syn-
thesis. In fact, ATP levels are reduced in Atgl/ macrophages, sug-
gesting that the lipolytic defect affects the usage of FAs as energy fuel.
As a consequence, decreased mitochondrial membrane potential,
reducedmitochondrial O2 consumption, elevated cytosolic Ca2þ, and
intracellular reactive oxygen species concentrations are observed in
Atgl/ macrophages [38]. Mitochondria in Atgl/ macrophages
are clustered around lipid droplets, are less electron dense andFig. 4. Transmission electron micrographs of small intestinal sections from Wt and intestin
small intestinal cells show intact mitochondria (M) albeit lipid droplet (LD) accumulation ismaller in sizewith aberrant cristae (Fig. 3), which provides evidence
of considerable mitochondrial dysfunction [38], indicating a highly
compromised mitochondrial function as a consequence of defective
lipolysis.
Fragmented mitochondria are deﬁning features of apoptosis.
Impaired mitochondria generate reactive oxygen species, which are
capable of acting as second messengers that mediate multiple
cellular responses, including apoptosis. Loading of macrophages
with unesteriﬁed cholesterol in vitro induces programmed cell death
via activation of the mitochondrial apoptosis pathway [39]. The
absence of ATGL inmacrophages, accompanied by TG accumulation,
also results in an increase of typicalmarkers of apoptosis [38] and ERe-speciﬁc Atgl/ mice. Section from Wt (upper panels) and Atgl/ (lower panels)
n Atgl/ small intestine. Scale bars: 0.5 mm.
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rophages might also be cytoprotective [41,42]. Differences between
the studies could be explained by additional mechanisms being
activated in Atgl/macrophages. A highly increased concentration
of the pro-apoptotic ceramide C16:0 might be responsible for in-
duction of apoptosis and mitochondrial dysfunction in Atgl/
macrophages [40]. The ﬁndings that Atgl/ macrophages can be
rescued from mitochondria fragmentation (Fig. 3), mitochondrial
dysfunction and apoptotic cell death but not from ER stress by in-
hibition of ceramide synthesis by fumonisin B1 treatment indicate
that C16:0 ceramide is essential and sufﬁcient for apoptosis and
mitochondrial dysfunction of Atgl/macrophages [40].
3.6. Other tissues
In the brain, intracellular FAs mediate the conversion into
signaling lipid molecules, including eicosanoids, DGs, phospho-
lipids, TGs, and fatty acyl carnitine species [43e45]. ATGL is
expressed in various brain regions, including pyramidal cells of the
hippocampus and the dentate gyrus, ependymal cells, and the
choroid plexus [46]. Recent data from brains of Atgl/ mice
indicate that ATGL affects cerebral TG catabolism, in particular in
regions in which brain metabolism interacts with the periphery
[46]. Intracellular TG lipolysis by ATGL may be important to
maintain FA supply and represents another mechanism of cerebral
lipid management. Since FA b-oxidation in the brain occurs only at
very low levels the impact of ATGL is expected to hardly inﬂuence
this process. Atgl/ mice show no sign of neurodegeneration,
whichmight be due to the fact that 12e16week oldmicewere used
for the study [46].
ATGL has very recently been identiﬁed as an important TG hy-
drolase of the small intestine [47]. Absence of intestinal ATGL
modulates PPARa signaling, thereby inﬂuencing the rate of FFA and
cholesterol uptake from the intestinal lumen. Further data from this
study revealed that intestinal ATGL deﬁciency has no inﬂuence on
chylomicron production, suggesting that lipolytic products gener-
ated by ATGL are not used for intestinal lipoprotein production. The
effects of intestinal ATGL deﬁciency on mitochondrial function are
still elusive. However, as observed in liver and heart [14], genes
involved in b-oxidation are down-regulated in the small intestine
of fasted intestine-speciﬁc Atgl/ mice, arguing for a decrease in
b-oxidation rate [47]. Intact mitochondria albeit lipid droplet
accumulation (Fig. 4) and unchanged mRNA expression of PGC-1a
in Atgl/ intestine (Obrowsky et al., unpublished observation)
indicate normal mitochondrial biogenesis and function in Atgl/
enterocytes. Downregulation of glutathion-S-transferases [47],
which are important for the detoxiﬁcation of xenobiotics and lipid
peroxidation products [48,49], suggest that intestinal ATGL might
play a role in the protection from oxidative stress.
Knockdown of ATGL in pancreatic INS832/13 cells and its
absence in pancreas of Atgl/ mice results in w3-fold increased
TG concentrations [50]. All ﬁndings published in this report (un-
changed glucose oxidation, mitochondrial membrane potential,
glucose usage, FA oxidation, and insulin content) illustrate that
moderate increases in TG content within the pancreas protect
against lipotoxicity, resulting in intact mitochondrial function.
4. Conclusion
Despite TG accumulation in all investigated Atgl/ cells and
tissues, current data on ATGL deﬁciency demonstrate that ATGL has
pleiotropic roles in mediating mitochondrial function, depending
on the type of cell or tissue. It is likely that ATGL-mediated lipolysis
in cardiac muscle, BAT, and macrophages activates PPARa (and d)
through ligand-dependent and ligand-independent mechanisms toregulate mitochondrial gene expression and FA oxidation, thereby
strongly inﬂuencing mitochondrial function. In the liver, ATGL
deﬁciency leads to an upregulation of PGC-1a and PGC-1b, sug-
gesting unchanged or even increased hepatic mitochondrial
biosynthesis. According to studies performed so far defective
lipolysis in skeletal muscle, WAT, small intestine, and pancreas has
no impact on mitochondrial function. Numerous questions,
including why ATGL exerts mitochondrial dysfunction in some but
not all tissues, remain unanswered. Additional studies are neces-
sary to answer the question whether tissue- or cell-speciﬁc tar-
geting of ATGL might be a potential drug target for pharmaceutical
intervention in humans.
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